Pub Date : 2025-02-01Epub Date: 2024-12-20DOI: 10.1016/j.clnesp.2024.12.018
Jixun Zhao, Yuyang Qiu, Huiqun Wang
Background: Although the primary impairment involved in Cerebral palsy (CP) is motor function, malnutrition is also common. However, there is a lack of tool recommendations for early malnutrition risk screening in children with CP, and the means of nutritional intervention for children with CP are also limited.
Methods: This study systematically searched the literature about clinical nutrition related content of cerebral palsy in Pubmed, MEDLINE, Embase, and the Cochrane Library in Jan 2024 and by hand searching, and we checked reference lists and citations to identify additional studies. Search terms include cerebral palsy, children, diagnosis, prediction, malnutrition, nutritional risk screening, nutritional assessment, nutritional support. Additions are marked in red in the modified version.
Results: The timing of diagnosis of CP has been moving forward, and some new diagnostic tools have been developed. Nutritional status is correlated with regional economic level, but there is still a malnutrition rate of nearly 30 % in developed countries. Severe restrictions in terms of gross motor function, swallowing dysfunction, feeding difficulties, cognitive impairment, and insufficient energy intake are common risk factors for malnutrition in children with CP. Z-score should be calculated in combination with measurement indicators in the assessment of physical development of children with CP. The nutritional outcomes of children with CP can be improved by various means, including diversified a Nutrition Support Team (NST) interventions.
Conclusions: The incidence of malnutrition in children with CP is high, which needs to be paid more attention. More effective malnutrition risk screening tools need to be developed for children with CP to guide the implementation of comprehensive and personalized nutritional interventions and improve malnutrient-related outcomes.
{"title":"Nutritional risk screening and nutritional assessment for children with cerebral palsy: A review of the current research status and future directions.","authors":"Jixun Zhao, Yuyang Qiu, Huiqun Wang","doi":"10.1016/j.clnesp.2024.12.018","DOIUrl":"10.1016/j.clnesp.2024.12.018","url":null,"abstract":"<p><strong>Background: </strong>Although the primary impairment involved in Cerebral palsy (CP) is motor function, malnutrition is also common. However, there is a lack of tool recommendations for early malnutrition risk screening in children with CP, and the means of nutritional intervention for children with CP are also limited.</p><p><strong>Methods: </strong>This study systematically searched the literature about clinical nutrition related content of cerebral palsy in Pubmed, MEDLINE, Embase, and the Cochrane Library in Jan 2024 and by hand searching, and we checked reference lists and citations to identify additional studies. Search terms include cerebral palsy, children, diagnosis, prediction, malnutrition, nutritional risk screening, nutritional assessment, nutritional support. Additions are marked in red in the modified version.</p><p><strong>Results: </strong>The timing of diagnosis of CP has been moving forward, and some new diagnostic tools have been developed. Nutritional status is correlated with regional economic level, but there is still a malnutrition rate of nearly 30 % in developed countries. Severe restrictions in terms of gross motor function, swallowing dysfunction, feeding difficulties, cognitive impairment, and insufficient energy intake are common risk factors for malnutrition in children with CP. Z-score should be calculated in combination with measurement indicators in the assessment of physical development of children with CP. The nutritional outcomes of children with CP can be improved by various means, including diversified a Nutrition Support Team (NST) interventions.</p><p><strong>Conclusions: </strong>The incidence of malnutrition in children with CP is high, which needs to be paid more attention. More effective malnutrition risk screening tools need to be developed for children with CP to guide the implementation of comprehensive and personalized nutritional interventions and improve malnutrient-related outcomes.</p>","PeriodicalId":10352,"journal":{"name":"Clinical nutrition ESPEN","volume":" ","pages":"382-389"},"PeriodicalIF":2.9,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142876453","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-02-01Epub Date: 2024-11-29DOI: 10.1016/j.clnesp.2024.11.023
Jens Bräunlich, Alexander Dinse-Lambracht
Background & aims: Vitamin D deficiency is defined by most experts as a level of less than 20 ng/ml. Studies have shown a relationship between musculoskeletal pain, muscle weakness, headache, and fatigue with low vitamin D level. The term Post-Corona Virus-19 Disease syndrome (PCS) describes new, returning or ongoing symptoms more than 12 weeks after Corona Virus Disease -19 (COVID-19) infection which cannot be explained by any other disorders or illnesses. The most prominent symptoms in PCS are fatigue, headache, and attention disorders. These similarities in PCS and vitamin D deficiency leads to the hypothesis of an association. The aim of this study was to find possible differences in vitamin D levels between PCS patients and a control group without PCS.
Methods: We measured vitamin D levels from April 2021 to December 2022 in 75 (2021) and 73 (2022) subjects (PCS) and compared these values with data from 2019 to 2022 in a non-PCS control group (non-PCS).
Results: We found significantly lower (p < 0,05) vitamin D levels in the PCS cohort (2021: 17,04 ± 8,0 ng/ml; 2022: 17,6 ± 6,6 ng/ml) compared to all years of the non-PCS group (2019: 23,7 ± 14,7 ng/ml; 2020:22,3 ± 13,7 ng/ml; 2021: 22,4 ± 12,3 ng/ml; 2022: 22,6 ± 11,0 ng/ml). There were no significant differences in vitamin D levels within the different years of the non-PCS group and when comparing the two PCS groups.
Conclusion: The results of the study recorded for the first-time decreased vitamin D values in a PCS cohort compared to a control group. This raises the question of whether vitamin D deficiency influences PCS symptoms or whether they are merely the consequences of the limitations of PCS.
{"title":"Decreased levels of vitamin D in Post-Corona Virus-19 Disease syndrome (PCS) patients compared to a control group.","authors":"Jens Bräunlich, Alexander Dinse-Lambracht","doi":"10.1016/j.clnesp.2024.11.023","DOIUrl":"10.1016/j.clnesp.2024.11.023","url":null,"abstract":"<p><strong>Background & aims: </strong>Vitamin D deficiency is defined by most experts as a level of less than 20 ng/ml. Studies have shown a relationship between musculoskeletal pain, muscle weakness, headache, and fatigue with low vitamin D level. The term Post-Corona Virus-19 Disease syndrome (PCS) describes new, returning or ongoing symptoms more than 12 weeks after Corona Virus Disease -19 (COVID-19) infection which cannot be explained by any other disorders or illnesses. The most prominent symptoms in PCS are fatigue, headache, and attention disorders. These similarities in PCS and vitamin D deficiency leads to the hypothesis of an association. The aim of this study was to find possible differences in vitamin D levels between PCS patients and a control group without PCS.</p><p><strong>Methods: </strong>We measured vitamin D levels from April 2021 to December 2022 in 75 (2021) and 73 (2022) subjects (PCS) and compared these values with data from 2019 to 2022 in a non-PCS control group (non-PCS).</p><p><strong>Results: </strong>We found significantly lower (p < 0,05) vitamin D levels in the PCS cohort (2021: 17,04 ± 8,0 ng/ml; 2022: 17,6 ± 6,6 ng/ml) compared to all years of the non-PCS group (2019: 23,7 ± 14,7 ng/ml; 2020:22,3 ± 13,7 ng/ml; 2021: 22,4 ± 12,3 ng/ml; 2022: 22,6 ± 11,0 ng/ml). There were no significant differences in vitamin D levels within the different years of the non-PCS group and when comparing the two PCS groups.</p><p><strong>Conclusion: </strong>The results of the study recorded for the first-time decreased vitamin D values in a PCS cohort compared to a control group. This raises the question of whether vitamin D deficiency influences PCS symptoms or whether they are merely the consequences of the limitations of PCS.</p>","PeriodicalId":10352,"journal":{"name":"Clinical nutrition ESPEN","volume":" ","pages":"246-248"},"PeriodicalIF":2.9,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142766894","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-02-01Epub Date: 2024-12-05DOI: 10.1016/j.clnesp.2024.11.036
Carolina Dumke de Siqueira, Leandro Borges, Tamara Dal Mora, Najla Adel Saleh, Elizabeth Soethe Alves, Sandro Wopereis, Beatriz Garcia Mendes, Ana Carolina Rabello de Moraes, Elaine Hatanaka, Fabíola Branco Filippin-Monteiro
Background & aims: Breastfeeding can be challenging in mothers with overweight or obesity-related chronic low-grade inflammation, resulting in negative consequences for the newborn. The pre-gestational body mass index is negatively associated with lactogenesis II, the onset of colostrum secretion. Herein, we evaluated mothers' inflammation, metabolic status, and components of breast milk after birth to associate these factors with their nutritional and breastfeeding status.
Methods: The study included volunteer mothers, categorized based on their nutritional status and anthropometric parameters, who gave birth in a tertiary maternity hospital. Serum and breast milk samples were collected 24 and 48 h after birth to determine inflammatory biomarkers (SAA, leptin, CRP, IL-1β, TNF-α, IL-8, IL-6, MCP-1, IL-10, and IFN-γ), reproductive hormones (prolactin and progesterone), as well as the breast milk composition (total protein, fatty acid, percentage of fat and Kcal). Furthermore, we conducted a six-month follow-up to assess breastfeeding outcomes. Interestingly, the composition of breast milk did not vary in the different situations analyzed, indicating the stability of the breast milk's composition in meeting infant needs, regardless of age, nutritional status, and type of birth.
Results: Our findings revealed a higher concentration of pro-inflammatory biomarkers (SAA, CRP, TNF-α, IL-8, and IFN-γ) than anti-inflammatory, IL-10, in breast milk. Our study showed that mothers who were overweight after pregnancy had a newborn with a higher birth weight compared to healthy post-pregnancy weight. Our study elucidates the intricate dynamics between maternal weight, inflammation, and breastfeeding outcomes.
Conclusions: While maternal overweight or obesity-related inflammation may pose challenges to lactogenesis II and influence newborn birth weight, breast milk remains a stable and reliable source of essential nutrients for infant nourishment. However, the presence of pro-inflammatory biomarkers in breast milk warrants further investigation into its potential implications for infant health.
{"title":"Early postnatal effects of maternal obesity on breast milk composition and breastfeeding outcomes.","authors":"Carolina Dumke de Siqueira, Leandro Borges, Tamara Dal Mora, Najla Adel Saleh, Elizabeth Soethe Alves, Sandro Wopereis, Beatriz Garcia Mendes, Ana Carolina Rabello de Moraes, Elaine Hatanaka, Fabíola Branco Filippin-Monteiro","doi":"10.1016/j.clnesp.2024.11.036","DOIUrl":"10.1016/j.clnesp.2024.11.036","url":null,"abstract":"<p><strong>Background & aims: </strong>Breastfeeding can be challenging in mothers with overweight or obesity-related chronic low-grade inflammation, resulting in negative consequences for the newborn. The pre-gestational body mass index is negatively associated with lactogenesis II, the onset of colostrum secretion. Herein, we evaluated mothers' inflammation, metabolic status, and components of breast milk after birth to associate these factors with their nutritional and breastfeeding status.</p><p><strong>Methods: </strong>The study included volunteer mothers, categorized based on their nutritional status and anthropometric parameters, who gave birth in a tertiary maternity hospital. Serum and breast milk samples were collected 24 and 48 h after birth to determine inflammatory biomarkers (SAA, leptin, CRP, IL-1β, TNF-α, IL-8, IL-6, MCP-1, IL-10, and IFN-γ), reproductive hormones (prolactin and progesterone), as well as the breast milk composition (total protein, fatty acid, percentage of fat and Kcal). Furthermore, we conducted a six-month follow-up to assess breastfeeding outcomes. Interestingly, the composition of breast milk did not vary in the different situations analyzed, indicating the stability of the breast milk's composition in meeting infant needs, regardless of age, nutritional status, and type of birth.</p><p><strong>Results: </strong>Our findings revealed a higher concentration of pro-inflammatory biomarkers (SAA, CRP, TNF-α, IL-8, and IFN-γ) than anti-inflammatory, IL-10, in breast milk. Our study showed that mothers who were overweight after pregnancy had a newborn with a higher birth weight compared to healthy post-pregnancy weight. Our study elucidates the intricate dynamics between maternal weight, inflammation, and breastfeeding outcomes.</p><p><strong>Conclusions: </strong>While maternal overweight or obesity-related inflammation may pose challenges to lactogenesis II and influence newborn birth weight, breast milk remains a stable and reliable source of essential nutrients for infant nourishment. However, the presence of pro-inflammatory biomarkers in breast milk warrants further investigation into its potential implications for infant health.</p>","PeriodicalId":10352,"journal":{"name":"Clinical nutrition ESPEN","volume":" ","pages":"365-374"},"PeriodicalIF":2.9,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142791244","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-02-01Epub Date: 2024-11-12DOI: 10.1016/j.clnesp.2024.11.002
Lara J Bou Malhab, Mohamed I Madkour, Dana N Abdelrahim, Leen Eldohaji, Maha Saber-Ayad, Nabil Eid, Wael M Abdel-Rahman, MoezAlIslam E Faris
Aim and background: A growing body of evidence supports the impact of intermittent fasting (IF) on longevity and healthy aging via the modulation of autophagy genes. The activation of the catabolic autophagic machinery (LAMP2, LC3B, ATG5, and ATG4D) has protective effects against degenerative aging and chronic diseases. This research examined the changes in the expression of the aforementioned genes upon the observance of dawn-to-dusk IF among metabolically healthy participants with overweight and obesity.
Methods: Fifty-one (51) participants (36 males and 15 females, 38.84 ± 11.73 years) with overweight and obesity (BMI = 29.75 ± 5.04 kg/m2) were recruited and monitored before and at the end of the commencement of the four-week IF. Six healthy subjects with normal BMI (21.4 ± 2.20 kg/m2) were recruited only to standardize the reference for normal levels of gene expressions. At the two time points, anthropometric, biochemical, and dietary assessments were performed, and LAMP2, LC3B, ATG5, and ATG4D gene expressions were assessed using qRT-PCR on RNA extracted from whole blood samples.
Results: At the end of IF, and compared to the pre-fasting levels, the relative gene expressions among participants with overweight/obesity were significantly increased for the three autophagy genes LAMP2, LC3B, and ATG5, with increments of about 4.2 folds, 1.9-fold, and 1.4-fold, respectively. In contrast, the increase in the ATG4D gene was not significant. Concomitantly, significant decreases were found in body weight, BMI, fat mass, body fat percent, hip and waist circumferences, LDL, IL-6, and TNF-a (P < 0.05), While HDL, IL-10, and CD163 significantly increased (P < 0.05). Binary logistic regression analysis for genetic expressions showed no significant association between high-energy intake, waist circumference, or obesity and the four gene expressions.
Conclusions: Four consecutive weeks of dawn-to-dusk IF of Ramadan is associated with the upregulation of autophagy gene expressions in participants with overweight/obesity, and this may explain, at least in part, its favorable short-term temporal metabolic and health-improving effects on early aging-related markers. Hence, IF presumably may entail a protective impact against early markers of aging and metabolic diseases in participants with overweight/obesity.
{"title":"Dawn-to-dusk intermittent fasting is associated with overexpression of autophagy genes: A prospective study on overweight and obese cohort.","authors":"Lara J Bou Malhab, Mohamed I Madkour, Dana N Abdelrahim, Leen Eldohaji, Maha Saber-Ayad, Nabil Eid, Wael M Abdel-Rahman, MoezAlIslam E Faris","doi":"10.1016/j.clnesp.2024.11.002","DOIUrl":"10.1016/j.clnesp.2024.11.002","url":null,"abstract":"<p><strong>Aim and background: </strong>A growing body of evidence supports the impact of intermittent fasting (IF) on longevity and healthy aging via the modulation of autophagy genes. The activation of the catabolic autophagic machinery (LAMP2, LC3B, ATG5, and ATG4D) has protective effects against degenerative aging and chronic diseases. This research examined the changes in the expression of the aforementioned genes upon the observance of dawn-to-dusk IF among metabolically healthy participants with overweight and obesity.</p><p><strong>Methods: </strong>Fifty-one (51) participants (36 males and 15 females, 38.84 ± 11.73 years) with overweight and obesity (BMI = 29.75 ± 5.04 kg/m<sup>2</sup>) were recruited and monitored before and at the end of the commencement of the four-week IF. Six healthy subjects with normal BMI (21.4 ± 2.20 kg/m<sup>2</sup>) were recruited only to standardize the reference for normal levels of gene expressions. At the two time points, anthropometric, biochemical, and dietary assessments were performed, and LAMP2, LC3B, ATG5, and ATG4D gene expressions were assessed using qRT-PCR on RNA extracted from whole blood samples.</p><p><strong>Results: </strong>At the end of IF, and compared to the pre-fasting levels, the relative gene expressions among participants with overweight/obesity were significantly increased for the three autophagy genes LAMP2, LC3B, and ATG5, with increments of about 4.2 folds, 1.9-fold, and 1.4-fold, respectively. In contrast, the increase in the ATG4D gene was not significant. Concomitantly, significant decreases were found in body weight, BMI, fat mass, body fat percent, hip and waist circumferences, LDL, IL-6, and TNF-a (P < 0.05), While HDL, IL-10, and CD163 significantly increased (P < 0.05). Binary logistic regression analysis for genetic expressions showed no significant association between high-energy intake, waist circumference, or obesity and the four gene expressions.</p><p><strong>Conclusions: </strong>Four consecutive weeks of dawn-to-dusk IF of Ramadan is associated with the upregulation of autophagy gene expressions in participants with overweight/obesity, and this may explain, at least in part, its favorable short-term temporal metabolic and health-improving effects on early aging-related markers. Hence, IF presumably may entail a protective impact against early markers of aging and metabolic diseases in participants with overweight/obesity.</p>","PeriodicalId":10352,"journal":{"name":"Clinical nutrition ESPEN","volume":" ","pages":"209-217"},"PeriodicalIF":2.9,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142616064","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-02-01Epub Date: 2024-11-28DOI: 10.1016/j.clnesp.2024.11.026
Tatiana Palotta Minari, Carolina Freitas Manzano, Louise Buonalumi Tácito Yugar, Luis Gustavo Sedenho-Prado, Tatiane de Azevedo Rubio, Lúcia Helena Bonalumi Tácito, Antônio Carlos Pires, José Fernando Vilela-Martin, Luciana Neves Cosenso-Martin, Nelson Dinamarco Ludovico, André Fattori, Juan Carlos Yugar-Toledo, Heitor Moreno, Luciana Pellegrini Pisani
Background & aims: Meal timing is an emerging branch of science that investigates the influence of eating patterns on the circadian rhythm and overall health. There are still discrepancies in the literature as to whether late distribution of food intake and sleep disorders could impact biochemical, anthropometric, and cardiovascular markers. The objectives of this study were firstly observe skipping breakfast and sleep disorders over 12 months. Secondarily, analyze the individual influence of these findings on changes biochemical, anthropometric, and cardiovascular markers during the same period.
Methods: This descriptive study is part of a tertiary analysis in a recently published study. This research recruited 84 participants with Type 2 Diabetes (T2D) who were divided: Control-40 participants received only medical care; Intervention-44 participants received the same medical care along with nutritional assessment. Consultations occurred quarterly over 12th months, and a follow-up was conducted after 3 months. For influence analysis, non-normal variables were compared using Mann-Whitney, while normal variables were compared using unpaired t-tests. In all instances, α = 0.05 and P < 0.05 were adopted.
Results: Analysis revealed a high percentage of patients in both groups who skipped breakfast, slept less than 6 h, and experienced nighttime awakenings during the 1st visit. By the 12th month, there was deterioration in all data in the control group and significant improvement in the intervention group. Those with sleep disturbances also had lower HDL-cholesterol (HDL-C) values (p = 0.0054). For the other analyzes no significant differences were found.
Conclusion: Participants who skipped breakfast and had more nocturnal awakenings possibly had worse glycemic and weight control, but this difference was not statistically significant and only trends were observed. Sleep disorders could affect HDL-C levels. However, the influence analysis does not establish a causal relationship and more clinical trials are needed to analyze this topic on T2D.
背景与目的:进餐时间是研究饮食模式对昼夜节律和整体健康影响的一个新兴科学分支。关于食物摄入和睡眠障碍的晚分布是否会影响生物化学、人体测量学和心血管指标,文献中仍然存在差异。本研究的目的首先是在12个月内观察不吃早餐和睡眠障碍。其次,分析这些发现在同一时期对生化、人体测量和心血管指标变化的个体影响。方法:该描述性研究是最近发表的一项研究的三级分析的一部分。这项研究招募了84名2型糖尿病患者(T2D),他们被分为两组:对照组40人只接受医疗护理;干预44的参与者在接受营养评估的同时也接受了同样的医疗护理。在12个月内每季度进行一次咨询,3个月后进行随访。对于影响分析,使用Mann-Whitney比较非正态变量,而使用非配对t检验比较正态变量。各试验均采用α = 0.05, P < 0.05。结果:分析显示,两组患者在第一次就诊时不吃早餐、睡眠时间少于6小时、夜间醒来的比例都很高。到第12个月时,对照组所有数据均出现恶化,干预组有明显改善。睡眠障碍患者的高密度脂蛋白胆固醇(HDL-C)值也较低(p=0.0054)。对于其他分析,没有发现显著差异。结论:不吃早餐和夜间醒来较多的参与者可能血糖和体重控制较差,但这种差异没有统计学意义,只观察到趋势。睡眠障碍会影响HDL-C水平。然而,影响分析并没有建立因果关系,需要更多的临床试验来分析T2D的这一主题。
{"title":"The effect of breakfast skipping and sleep disorders on glycemic control, cardiovascular risk, and weight loss in type 2 diabetes.","authors":"Tatiana Palotta Minari, Carolina Freitas Manzano, Louise Buonalumi Tácito Yugar, Luis Gustavo Sedenho-Prado, Tatiane de Azevedo Rubio, Lúcia Helena Bonalumi Tácito, Antônio Carlos Pires, José Fernando Vilela-Martin, Luciana Neves Cosenso-Martin, Nelson Dinamarco Ludovico, André Fattori, Juan Carlos Yugar-Toledo, Heitor Moreno, Luciana Pellegrini Pisani","doi":"10.1016/j.clnesp.2024.11.026","DOIUrl":"10.1016/j.clnesp.2024.11.026","url":null,"abstract":"<p><strong>Background & aims: </strong>Meal timing is an emerging branch of science that investigates the influence of eating patterns on the circadian rhythm and overall health. There are still discrepancies in the literature as to whether late distribution of food intake and sleep disorders could impact biochemical, anthropometric, and cardiovascular markers. The objectives of this study were firstly observe skipping breakfast and sleep disorders over 12 months. Secondarily, analyze the individual influence of these findings on changes biochemical, anthropometric, and cardiovascular markers during the same period.</p><p><strong>Methods: </strong>This descriptive study is part of a tertiary analysis in a recently published study. This research recruited 84 participants with Type 2 Diabetes (T2D) who were divided: Control-40 participants received only medical care; Intervention-44 participants received the same medical care along with nutritional assessment. Consultations occurred quarterly over 12th months, and a follow-up was conducted after 3 months. For influence analysis, non-normal variables were compared using Mann-Whitney, while normal variables were compared using unpaired t-tests. In all instances, α = 0.05 and P < 0.05 were adopted.</p><p><strong>Results: </strong>Analysis revealed a high percentage of patients in both groups who skipped breakfast, slept less than 6 h, and experienced nighttime awakenings during the 1st visit. By the 12th month, there was deterioration in all data in the control group and significant improvement in the intervention group. Those with sleep disturbances also had lower HDL-cholesterol (HDL-C) values (p = 0.0054). For the other analyzes no significant differences were found.</p><p><strong>Conclusion: </strong>Participants who skipped breakfast and had more nocturnal awakenings possibly had worse glycemic and weight control, but this difference was not statistically significant and only trends were observed. Sleep disorders could affect HDL-C levels. However, the influence analysis does not establish a causal relationship and more clinical trials are needed to analyze this topic on T2D.</p>","PeriodicalId":10352,"journal":{"name":"Clinical nutrition ESPEN","volume":" ","pages":"172-181"},"PeriodicalIF":2.9,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142766901","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-02-01Epub Date: 2024-12-10DOI: 10.1016/j.clnesp.2024.12.009
Tülay Tiftik, Murat Kara, Cevriye Mülkoğlu, İrem Çiftçi, Ömer Faruk Çelik, Mahmut Esad Durmuş, Özgür Kara, Şerife Mehlika Kuşkonmaz, Hakan Genç, Bayram Kaymak, Levent Özçakar
Introduction: Type 2 diabetes mellitus (DM), osteoporosis (OP) and sarcopenia are major public health problems related with higher fall/fracture risks, morbidity and mortality. Due to the lack of a comprehensive analysis among OP, sarcopenia and DM; we aimed to explore the relationships between DM and the aforementioned conditions in postmenopausal women.
Methods: This cross-sectional study included postmenopausal women who consecutively admitted to the Departments of Physical & Rehabilitation Medicine, and Endocrinology and Metabolism. Demographic data, nutrition/cognition status and frailty scores of the participants were recorded. Sarcopenia-related parameters including, anterior thigh muscle thickness, handgrip strength, chair stand test, gait speed, and one-leg stand test (OLST) were measured. ISarcoPRM algorithm was used for the diagnosis of sarcopenia.
Results: A total of 444 postmenopausal women were consecutively enrolled. DM patients (N = 158) had higher frequency of sarcopenia (23.4 % vs. 12.9 %), but lower frequency of OP (33.5 % vs. 50.7 %) than controls (both p < 0.01). As regards regression analyses; menopause duration was positively (OR: 1.054, 95 % CI 1.030-1.077), but weight (OR: 0.957, 95 % CI 0.940-0.975) and DM (OR: 0.477, 95 % CI 0.310-0.733) were negatively related with OP (all p < 0.001). On the other hand, age (OR: 1.094, 95 % CI 1.056-1.133), body mass index (OR: 1.131, 95 % CI 1.067-1.198), and DM (OR: 1.887, 95 % CI 1.107-3.218) were positively related with sarcopenia (all p < 0.05). In addition, age (β = -0.355, p < 0.001), body mass index (β = -0.108, p = 0.021) and DM (β = -0.209, p < 0.001) were negatively related with OLST values.
Conclusion: DM has paradoxical associations with bone mass and muscle mass/function. Although it has negative relationship with OP (about two times lower odds), it has positive relationship with sarcopenia (about two times higher odds).
导言:2型糖尿病(DM)、骨质疏松症(OP)和肌肉疏松症是与较高的跌倒/骨折风险、发病率和死亡率相关的主要公共健康问题。由于缺乏对骨质疏松症、肌肉疏松症和糖尿病之间关系的全面分析,我们旨在探讨绝经后女性糖尿病与上述疾病之间的关系:这项横断面研究包括连续在物理与康复医学科、内分泌与代谢科住院的绝经后妇女。研究人员记录了参与者的人口统计学数据、营养/认知状况和虚弱评分。测量了与 "肌肉疏松症 "相关的参数,包括大腿前侧肌肉厚度、手握力、椅子站立测试、步速和单腿站立测试(OLST)。采用 ISarcoPRM 算法诊断肌肉疏松症:结果:共有 444 名绝经后妇女连续入选。与对照组相比,DM 患者(158 人)出现肌少症的频率较高(23.4% 对 12.9%),但出现 OP 的频率较低(33.5% 对 50.7%):DM与骨量和肌肉质量/功能的关系自相矛盾。虽然它与 OP 呈负相关(几率低约两倍),但与肌肉疏松症呈正相关(几率高约两倍)。
{"title":"The Paradoxical Relationship Among Diabetes Mellitus, Osteoporosis and Sarcopenia: The PARADOS Study.","authors":"Tülay Tiftik, Murat Kara, Cevriye Mülkoğlu, İrem Çiftçi, Ömer Faruk Çelik, Mahmut Esad Durmuş, Özgür Kara, Şerife Mehlika Kuşkonmaz, Hakan Genç, Bayram Kaymak, Levent Özçakar","doi":"10.1016/j.clnesp.2024.12.009","DOIUrl":"10.1016/j.clnesp.2024.12.009","url":null,"abstract":"<p><strong>Introduction: </strong>Type 2 diabetes mellitus (DM), osteoporosis (OP) and sarcopenia are major public health problems related with higher fall/fracture risks, morbidity and mortality. Due to the lack of a comprehensive analysis among OP, sarcopenia and DM; we aimed to explore the relationships between DM and the aforementioned conditions in postmenopausal women.</p><p><strong>Methods: </strong>This cross-sectional study included postmenopausal women who consecutively admitted to the Departments of Physical & Rehabilitation Medicine, and Endocrinology and Metabolism. Demographic data, nutrition/cognition status and frailty scores of the participants were recorded. Sarcopenia-related parameters including, anterior thigh muscle thickness, handgrip strength, chair stand test, gait speed, and one-leg stand test (OLST) were measured. ISarcoPRM algorithm was used for the diagnosis of sarcopenia.</p><p><strong>Results: </strong>A total of 444 postmenopausal women were consecutively enrolled. DM patients (N = 158) had higher frequency of sarcopenia (23.4 % vs. 12.9 %), but lower frequency of OP (33.5 % vs. 50.7 %) than controls (both p < 0.01). As regards regression analyses; menopause duration was positively (OR: 1.054, 95 % CI 1.030-1.077), but weight (OR: 0.957, 95 % CI 0.940-0.975) and DM (OR: 0.477, 95 % CI 0.310-0.733) were negatively related with OP (all p < 0.001). On the other hand, age (OR: 1.094, 95 % CI 1.056-1.133), body mass index (OR: 1.131, 95 % CI 1.067-1.198), and DM (OR: 1.887, 95 % CI 1.107-3.218) were positively related with sarcopenia (all p < 0.05). In addition, age (β = -0.355, p < 0.001), body mass index (β = -0.108, p = 0.021) and DM (β = -0.209, p < 0.001) were negatively related with OLST values.</p><p><strong>Conclusion: </strong>DM has paradoxical associations with bone mass and muscle mass/function. Although it has negative relationship with OP (about two times lower odds), it has positive relationship with sarcopenia (about two times higher odds).</p>","PeriodicalId":10352,"journal":{"name":"Clinical nutrition ESPEN","volume":" ","pages":"258-263"},"PeriodicalIF":2.9,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142817172","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-02-01Epub Date: 2024-12-14DOI: 10.1016/j.clnesp.2024.12.011
Mauricio Chona Chona, Lina Maria López Basto, Carolina Pinzón Ospina, Ana Cristina Pardo Coronado, María Paula Guzmán Silva, Marjorie Marín, Alvaro Vallejos, Gloria Esperanza Castro Osmán, Carlos Saavedra, Jorge Díaz Rojas, Jorge Medina-Parra, Ricardo Alfonso Merchán-Chaverra
Background and objectives: Surgical resection is a first-line treatment for patients with cancer, but preoperative malnutrition is a risk factor for postoperative complications. This study aimed to evaluate the association between preoperative administration of an immunonutrition regimen and postoperative clinical outcomes in patients with cancer undergoing major abdominal surgery.
Methods: The Surgical Prehabilitation Multimodal Oncology (SUPREMO) retrospective cohort study, conducted from January 2021 to December 2023, included patients with cancer undergoing major abdominal surgery. Patients were categorized based on whether they received a complete immunonutrition regimen or an incomplete or no regimen. Demographic and clinical data were extracted from electronic health records for descriptive analysis. Logistic regression was used to assess the impact of immunonutrition on the risk of infectious complications, with clinical and demographic variables as explanatory factors.
Results: A total of 620 patients were included, with 49 % receiving a complete preoperative immunonutrition regimen. Bivariate analysis indicated that complete regimen administration was associated with lower intensive care unit (ICU) admission, invasive mechanical ventilation (IMV), and vasopressor support requirements (p = 0.005, p = 0.019, and p = 0.032, respectively). The logistic regression model showed a significant reduction in in-hospital infectious complications (odds ratio 0.54, 95 % confidence interval 0.31-0.98; p = 0.044).
Conclusion: Administering a complete preoperative immunonutrition regimen may be associated with reduced infectious complications, ICU and IMV requirements, and vasopressor support use.
{"title":"Preoperative immunonutrition and postoperative outcomes in patients with cancer undergoing major abdominal surgery: Retrospective cohort study.","authors":"Mauricio Chona Chona, Lina Maria López Basto, Carolina Pinzón Ospina, Ana Cristina Pardo Coronado, María Paula Guzmán Silva, Marjorie Marín, Alvaro Vallejos, Gloria Esperanza Castro Osmán, Carlos Saavedra, Jorge Díaz Rojas, Jorge Medina-Parra, Ricardo Alfonso Merchán-Chaverra","doi":"10.1016/j.clnesp.2024.12.011","DOIUrl":"10.1016/j.clnesp.2024.12.011","url":null,"abstract":"<p><strong>Background and objectives: </strong>Surgical resection is a first-line treatment for patients with cancer, but preoperative malnutrition is a risk factor for postoperative complications. This study aimed to evaluate the association between preoperative administration of an immunonutrition regimen and postoperative clinical outcomes in patients with cancer undergoing major abdominal surgery.</p><p><strong>Methods: </strong>The Surgical Prehabilitation Multimodal Oncology (SUPREMO) retrospective cohort study, conducted from January 2021 to December 2023, included patients with cancer undergoing major abdominal surgery. Patients were categorized based on whether they received a complete immunonutrition regimen or an incomplete or no regimen. Demographic and clinical data were extracted from electronic health records for descriptive analysis. Logistic regression was used to assess the impact of immunonutrition on the risk of infectious complications, with clinical and demographic variables as explanatory factors.</p><p><strong>Results: </strong>A total of 620 patients were included, with 49 % receiving a complete preoperative immunonutrition regimen. Bivariate analysis indicated that complete regimen administration was associated with lower intensive care unit (ICU) admission, invasive mechanical ventilation (IMV), and vasopressor support requirements (p = 0.005, p = 0.019, and p = 0.032, respectively). The logistic regression model showed a significant reduction in in-hospital infectious complications (odds ratio 0.54, 95 % confidence interval 0.31-0.98; p = 0.044).</p><p><strong>Conclusion: </strong>Administering a complete preoperative immunonutrition regimen may be associated with reduced infectious complications, ICU and IMV requirements, and vasopressor support use.</p>","PeriodicalId":10352,"journal":{"name":"Clinical nutrition ESPEN","volume":" ","pages":"324-330"},"PeriodicalIF":2.9,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142834286","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-02-01Epub Date: 2024-12-22DOI: 10.1016/j.clnesp.2024.12.020
Rafaela Rodrigues Vieira, Patrícia Zamberlan
Background: Nutritional intervention during hospitalisation is vital in managing of children and adolescents in intensive care. In this context, body composition measurements, such as mid-upper arm circumference (MUAC), can help improve the accuracy of nutritional assessments. However, using MUAC has some limitations. Calf circumference (CC) is a straightforward, inexpensive, and easily obtainable measurement. However, no reference values currently exist for CC in paediatric patients.
Aims: To describe the nutritional monitoring of critically ill children and adolescents in the Paediatric Intensive Care Unit (PICU) using CC.
Methods: Patients aged 6 months to 18 years old who were admitted to the PICUs participated in the study. Two MUAC and CC measurements were performed: one in the first 48 h of admission to the PICU and another after 7 days. The percentage change between the two measurements was compared. Information was also evaluated about demographic and outcome data. Analyses were conducted with all patients included in the sample collectively and subdivided by age (<10 years and ≥10 years).
Results: Two hundred and eleven patients underwent anthropometric assessment on admission, and the sample for comparative analyses consisted of 103 patients (after discharges and deaths). MUAC and CC significantly decreased in the first week of hospitalisation. A positive weak correlation was found between the percentage change in the MUAC and CC only for individuals under 10 years old and for the total sample, but not for adolescents. The all age group and children under 10 years old showed a greater reduction in CC than in MUAC. The same did not occur for adolescents.
Conclusions: Calf circumference may be a promising method for nutritional monitoring of critically ill children in Paediatric Intensive Care Units because it can indicate signs of depletion earlier than mid-upper arm circumference. These results are more meaningful for children than for adolescents.
{"title":"Calf circumference may complement the nutritional assessment of children under 10 in the paediatric intensive care unit.","authors":"Rafaela Rodrigues Vieira, Patrícia Zamberlan","doi":"10.1016/j.clnesp.2024.12.020","DOIUrl":"10.1016/j.clnesp.2024.12.020","url":null,"abstract":"<p><strong>Background: </strong>Nutritional intervention during hospitalisation is vital in managing of children and adolescents in intensive care. In this context, body composition measurements, such as mid-upper arm circumference (MUAC), can help improve the accuracy of nutritional assessments. However, using MUAC has some limitations. Calf circumference (CC) is a straightforward, inexpensive, and easily obtainable measurement. However, no reference values currently exist for CC in paediatric patients.</p><p><strong>Aims: </strong>To describe the nutritional monitoring of critically ill children and adolescents in the Paediatric Intensive Care Unit (PICU) using CC.</p><p><strong>Methods: </strong>Patients aged 6 months to 18 years old who were admitted to the PICUs participated in the study. Two MUAC and CC measurements were performed: one in the first 48 h of admission to the PICU and another after 7 days. The percentage change between the two measurements was compared. Information was also evaluated about demographic and outcome data. Analyses were conducted with all patients included in the sample collectively and subdivided by age (<10 years and ≥10 years).</p><p><strong>Results: </strong>Two hundred and eleven patients underwent anthropometric assessment on admission, and the sample for comparative analyses consisted of 103 patients (after discharges and deaths). MUAC and CC significantly decreased in the first week of hospitalisation. A positive weak correlation was found between the percentage change in the MUAC and CC only for individuals under 10 years old and for the total sample, but not for adolescents. The all age group and children under 10 years old showed a greater reduction in CC than in MUAC. The same did not occur for adolescents.</p><p><strong>Conclusions: </strong>Calf circumference may be a promising method for nutritional monitoring of critically ill children in Paediatric Intensive Care Units because it can indicate signs of depletion earlier than mid-upper arm circumference. These results are more meaningful for children than for adolescents.</p>","PeriodicalId":10352,"journal":{"name":"Clinical nutrition ESPEN","volume":" ","pages":"445-452"},"PeriodicalIF":2.9,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142881391","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-02-01Epub Date: 2024-11-26DOI: 10.1016/j.clnesp.2024.11.020
Miguel Alvarez-Mejia, Cesar Augusto Restrepo, Felipe Marulanda-Mejia, Clara Helena González-Correa
The relationship between sarcopenic obesity and hypovitaminosis D in individuals with chronic kidney disease is complex and has significant impacts on muscle and bone health. An observational, cross-sectional, and analytical study was conducted to analyze possible associations between serum vitamin D levels and sarcopenic obesity in patients with chronic kidney disease stages 3 and 4 in a cohort of patients under nephrology care. The presence of sarcopenic obesity was assessed using bioimpedance criteria, and vitamin D levels were measured and recorded for each patient. Statistically significant associations were found between sarcopenic obesity and suboptimal vitamin D levels (p < 0.005) as well as between severe sarcopenia and hypovitaminosis D (p < 0.05) in patients with chronic kidney disease stages 3 and 4. Patients with optimal levels of vitamin D showed better muscle quality and a lower prevalence of sarcopenia and severe sarcopenia. The findings suggest that vitamin D levels play a crucial role in muscle quality in patients with CKD stages 3 and 4. Maintaining optimal levels of vitamin D may help reduce the prevalence of sarcopenic obesity and improve quality of life in these patients.
{"title":"Association between hypovitaminosis D and sarcopenic obesity in patients with chronic kidney disease stages 3 and 4.","authors":"Miguel Alvarez-Mejia, Cesar Augusto Restrepo, Felipe Marulanda-Mejia, Clara Helena González-Correa","doi":"10.1016/j.clnesp.2024.11.020","DOIUrl":"10.1016/j.clnesp.2024.11.020","url":null,"abstract":"<p><p>The relationship between sarcopenic obesity and hypovitaminosis D in individuals with chronic kidney disease is complex and has significant impacts on muscle and bone health. An observational, cross-sectional, and analytical study was conducted to analyze possible associations between serum vitamin D levels and sarcopenic obesity in patients with chronic kidney disease stages 3 and 4 in a cohort of patients under nephrology care. The presence of sarcopenic obesity was assessed using bioimpedance criteria, and vitamin D levels were measured and recorded for each patient. Statistically significant associations were found between sarcopenic obesity and suboptimal vitamin D levels (p < 0.005) as well as between severe sarcopenia and hypovitaminosis D (p < 0.05) in patients with chronic kidney disease stages 3 and 4. Patients with optimal levels of vitamin D showed better muscle quality and a lower prevalence of sarcopenia and severe sarcopenia. The findings suggest that vitamin D levels play a crucial role in muscle quality in patients with CKD stages 3 and 4. Maintaining optimal levels of vitamin D may help reduce the prevalence of sarcopenic obesity and improve quality of life in these patients.</p>","PeriodicalId":10352,"journal":{"name":"Clinical nutrition ESPEN","volume":" ","pages":"205-208"},"PeriodicalIF":2.9,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142749983","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-02-01Epub Date: 2024-11-28DOI: 10.1016/j.clnesp.2024.11.013
Yijie Chen, Jun Chen, Ji Wu, Xianguo Qu, Zhifen Zhang
Background & aims: Primary ovarian insufficiency (POI) is a significant clinical syndrome that leads to female infertility, and its incidence continues to increase. We used metabolome-specific Mendelian randomization (MR) to identify causally associated metabolites and explore the relationship between candidate metabolites and upstream genetic variations.
Methods: The primary MR analysis utilized the inverse variance weighted (IVW) method as the primary approach to assess the causal relationship between exposure and POI. Multiple sensitivity analyses included MR-Egger, weighted median, and weighted mode methods.
Results: After using genetic variants as probes, we identified 27 metabolites of 278 that are associated with the risk of POI, including dodecanedioate (OR 0.052, 95 % CI 0.010-0.265; P < 0.001), adrenate (OR 0.113, 95 % CI 0.016-0.822; P = 0.031), indolepropionate (OR 0.174, 95 % CI 0.051-0.593; P = 0.005), homocitrulline (OR 0.194, 95 % CI 0.051-0.741; P = 0.016), and 3-methylhistidine (OR 0.404, 95 % CI 0.193-0.848; P = 0.017). Our study indicated the presence of heterogeneity; therefore, we employed the IVW random-effects model as the primary approach. KEGG pathway enrichment analysis identified six significant metabolic pathways, primarily including biosynthesis of unsaturated fatty acids, phenylalanine, tyrosine and tryptophan biosynthesis, aminoacyl-tRNA biosynthesis, linoleic acid metabolism, valine, leucine and isoleucine biosynthesis, ubiquinone and other terpenoid-quinone biosynthesis.
Conclusions: By integrating genomics and metabolomics, this study provides novel insights into the causal relationship linking circulating metabolites and the onset of POI.
背景与目的:原发性卵巢功能不全(POI)是导致女性不孕症的重要临床综合征,其发病率不断上升。我们使用代谢组特异性孟德尔随机化(MR)来确定因果相关的代谢物,并探索候选代谢物与上游遗传变异之间的关系。方法:主要MR分析采用逆方差加权(IVW)方法作为评估暴露与POI之间因果关系的主要方法。多重敏感性分析包括MR-Egger、加权中位数和加权模式方法。结果:在使用遗传变异作为探针后,我们从278例患者中鉴定出27种与POI风险相关的代谢物,包括十二烷二酸酯(OR 0.052, 95% CI 0.010 - 0.265;P < 0.001),肾上腺素(OR 0.113, 95% CI 0.016 - 0.822;P = 0.031),吲哚丙酸酯(OR 0.174, 95% CI 0.051 - 0.593;P = 0.005),均瓜氨酸(OR 0.194, 95% CI 0.051 - 0.741;P = 0.016)和3-甲基组氨酸(OR 0.404, 95% CI 0.193 - 0.848;P = 0.017)。我们的研究表明存在异质性;因此,我们采用IVW随机效应模型作为主要方法。KEGG途径富集分析确定了6条重要的代谢途径,主要包括不饱和脂肪酸的生物合成、苯丙氨酸、酪氨酸和色氨酸的生物合成、氨基酰基trna的生物合成、亚油酸的生物合成、缬氨酸、亮氨酸和异亮氨酸的生物合成、泛醌和其他萜类醌的生物合成。结论:通过整合基因组学和代谢组学,本研究为循环代谢物与POI发病之间的因果关系提供了新的见解。
{"title":"Metabolome-wide Mendelian randomization assessing the causal relationship between blood metabolites and primary ovarian insufficiency.","authors":"Yijie Chen, Jun Chen, Ji Wu, Xianguo Qu, Zhifen Zhang","doi":"10.1016/j.clnesp.2024.11.013","DOIUrl":"10.1016/j.clnesp.2024.11.013","url":null,"abstract":"<p><strong>Background & aims: </strong>Primary ovarian insufficiency (POI) is a significant clinical syndrome that leads to female infertility, and its incidence continues to increase. We used metabolome-specific Mendelian randomization (MR) to identify causally associated metabolites and explore the relationship between candidate metabolites and upstream genetic variations.</p><p><strong>Methods: </strong>The primary MR analysis utilized the inverse variance weighted (IVW) method as the primary approach to assess the causal relationship between exposure and POI. Multiple sensitivity analyses included MR-Egger, weighted median, and weighted mode methods.</p><p><strong>Results: </strong>After using genetic variants as probes, we identified 27 metabolites of 278 that are associated with the risk of POI, including dodecanedioate (OR 0.052, 95 % CI 0.010-0.265; P < 0.001), adrenate (OR 0.113, 95 % CI 0.016-0.822; P = 0.031), indolepropionate (OR 0.174, 95 % CI 0.051-0.593; P = 0.005), homocitrulline (OR 0.194, 95 % CI 0.051-0.741; P = 0.016), and 3-methylhistidine (OR 0.404, 95 % CI 0.193-0.848; P = 0.017). Our study indicated the presence of heterogeneity; therefore, we employed the IVW random-effects model as the primary approach. KEGG pathway enrichment analysis identified six significant metabolic pathways, primarily including biosynthesis of unsaturated fatty acids, phenylalanine, tyrosine and tryptophan biosynthesis, aminoacyl-tRNA biosynthesis, linoleic acid metabolism, valine, leucine and isoleucine biosynthesis, ubiquinone and other terpenoid-quinone biosynthesis.</p><p><strong>Conclusions: </strong>By integrating genomics and metabolomics, this study provides novel insights into the causal relationship linking circulating metabolites and the onset of POI.</p>","PeriodicalId":10352,"journal":{"name":"Clinical nutrition ESPEN","volume":" ","pages":"331-338"},"PeriodicalIF":2.9,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142766898","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}